BONE MINERAL GROUP
当科にはグループの垣根をこえた骨グループが存在します。骨は骨格を構成するだけではなく、腎臓・内分泌に関係する骨・ミネラル代謝など、その役割は多彩です。骨まで愛する当グループは、骨に関わる研究を共同で行ってきました。また日本骨粗鬆症学会認定医の育成にむけた勉強会も定期的に開催しています。興味のある方は是非ご連絡ください。
1. Ohmura K, Kato M, Watanabe T, Oku K, Bohgaki T, Horita T, Yasuda S, Ito YM, Sato N, Atsumi T. Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis. Arthritis Res Ther. 20(1):72. 2018
2. Fujieda Y, Doi M, Asaka T, Ota M, Hisada R, Ohnishi N, Kono M, Kameda H, Nakazawa D, Kato M, Amengual O, Takahata M, Yasuda S, Kitagawa Y, Atsumi T. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease. J Bone Miner Metab. 38(4):581-588.2020
3. Yamamoto J, Nakazawa D, Nishio S, Ishikawa Y, Makita M, Kusunoki Y, Nagai S, Fujieda Y, Takahata M, Yamada K, Yamamura T, Yotsukura A, Saito M, Shimazaki M, Atsumi T. Impact of Weekly Teriparatide on the Bone and Mineral Metabolism in Hemodialysis Patients With Relatively Low Serum Parathyroid Hormone: A Pilot Study. Ther Apher Dial.24(2):146-153. 2020.
4. Fujieda Y, Horita T, Nishimoto N, Tanimura K, Amasaki Y, Kasahara H, Furukawa S, Takeda T, Fukaya S, Matsui K, Tsutsumi A, Furusaki A, Sagawa A, Katayama K, Takeuchi K, Katsumata K, Kurita T, Shane P, Kato M, Oku K, Yasuda S, Takahata M, Iwasaki N, Atsumi T. Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial. Mod Rheumatol.31(3):593-599. 2021
5. Kato M, Michigami T, Tachikawa K, Kato M, Yabe I, Shimizu T, Asaka T, Kitagawa Y, Atsumi T.Novel mutation in the ALPL gene with a dominant negative effect in a Japanese family.J Bone Miner Metab.39(5):804-809. 2021